ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0993

Pulmonary Complications and Mortality Trends in Rheumatoid Arthritis Patients Aged 65 and Older in the United States: A CDC WONDER Database Analysis

Muhammad Naveed1, Rabia Iqbal1, Kishan Patel2, Ahila Ali1, Simran Bhimani3, Bazil Azeem4, Yash Deshpande3, Muhammad Omer Rehan1, Faizan Ahmed5, Hussain Haider Shah1 and Nouman Shafique6, 1Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan, 2Riverside Community Hospital, Riverside, CA, 3The Wright Center for graduate medical education, Scranton, PA, 4Shaheed Mohtarma Benazir Bhutto Medical College Liyari, Karachi, Pakistan, 5Ameer-ud-Din Medical College, Lahore, Pakistan, 6AdventHealth Orlando, Orlando, FL

Meeting: ACR Convergence 2024

Keywords: Epidemiology, pulmonary, race/ethnicity, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Pulmonary complications in rheumatoid arthritis (RA) are an important cause of mortality among older adults. This study analyzes trends and demographic disparities in mortality rates due to RA. Patients aged 65 and older from 1999 to 2020 in the United States were included in the study.

Methods: A retrospective analysis was conducted using the CDC WONDER database from 1999 to 2020. Age-adjusted mortality rates (AAMRs) per 100,000 persons were calculated, and trends were assessed using Average Annual Percentage Change (AAPC) and Annual Percent Change (APC). Data were stratified by year, sex, race/ethnicity, and geographical regions.

Results: Between 1999 and 2020, pulmonary complications in RA accounted for 73,164 deaths among older adults aged 65+ in the U.S. Deaths primarily occurred in medical facilities (49.0%). The overall AAMR decreased from 10.7 in 1999 to 8.3 in 2020, with an AAPC of -1.13 (95% CI: -1.58 to -0.79, p < 0.000001). The AAMR significantly declined from 1999 to 2018 (APC: -2.43, p < 0.000001), followed by a dramatic rise from 2018 to 2020 (APC: 12.11, p = 0.0016). Older women had higher AAMRs than men (women: 9.6; men: 5.8), with both sexes experiencing decreases (men: AAPC: -2.34, p < 0.000001; women: AAPC: -0.82, p < 0.000001). Among racial groups, American Indian or Alaska Natives had the highest AAMRs (15.1), followed by Whites (8.6), Hispanics (6.6), Black Africans (5.1), and Asians/ Pacific Islanders (4.0). AAMRs decreased for all races except Black African patients, with the largest decrease in Asians (AAPC: -1.48, p = 0.002). Geographically, AAMRs ranged from 4.0 in Nevada to 14.9 in Vermont, with the highest mortality in the Midwestern and Western regions (both AAMR: 9.3). Nonmetropolitan areas had higher AAMRs than metropolitan areas (nonmetropolitan: 10.3; metropolitan: 7.5), with both areas showing decreases from 1999 to 2020 (metropolitan AAPC: -1.19, p < 0.000001; nonmetropolitan AAPC: -1.07, p < 0.000001).

Conclusion: This analysis shows a decline in mortality rates due to pulmonary complications in RA among older adults in the U.S. However, a recent increase has been observed. Significant demographic and geographic disparities were noted in the results, highlighting the need for targeted interventions to improve health outcomes in affected populations.

Supporting image 1

Figure 1. Demographic Patterns and Inequalities in Mortality Due to Pulmonary Complications in Rheumatoid Arthritis Among Older Adults (≥ 65 years) in the United States, 1999_2020.


Disclosures: M. Naveed: None; R. Iqbal: None; K. Patel: None; A. Ali: None; S. Bhimani: None; B. Azeem: None; Y. Deshpande: None; M. Rehan: None; F. Ahmed: None; H. Shah: None; N. Shafique: None.

To cite this abstract in AMA style:

Naveed M, Iqbal R, Patel K, Ali A, Bhimani S, Azeem B, Deshpande Y, Rehan M, Ahmed F, Shah H, Shafique N. Pulmonary Complications and Mortality Trends in Rheumatoid Arthritis Patients Aged 65 and Older in the United States: A CDC WONDER Database Analysis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/pulmonary-complications-and-mortality-trends-in-rheumatoid-arthritis-patients-aged-65-and-older-in-the-united-states-a-cdc-wonder-database-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pulmonary-complications-and-mortality-trends-in-rheumatoid-arthritis-patients-aged-65-and-older-in-the-united-states-a-cdc-wonder-database-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology